| Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 | Dec'15 | Sep'15 | Jun'15 | Mar'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||||||||
Net loss | ||||||||||||
-31 | -2,023 | -30 | 3 | -63 | -24 | -32 | -37 | -148 | -137 | -224 | -85 | -25 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
Interest earned on Trust Account | ||||||||||||
29 | 35 | 51 | 55 | 40 | 26 | 20 | 18 | 15 | 1 | 1 | 1 | 0 |
Changes in operating assets and liabilities: | ||||||||||||
Prepaid expenses | ||||||||||||
5 | -19 | -9 | -19 | 44 | -22 | -22 | -22 | 19 | -29 | -31 | 4 | 106 |
Accounts payable and accrued expenses | ||||||||||||
-2 | 2,007 | 9 | -12 | 5 | -0 | -1 | -22 | 94 | -33 | 92 | 13 | 6 |
Net cash used in operating activities | ||||||||||||
-68 | - | - | - | -142 | - | - | - | - | - | - | - | - |
Accrued formation and offering costs | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 80 |
Net cash used in operating activities | ||||||||||||
- | - | - | - | - | - | - | -56 | -89 | -143 | -102 | -78 | -45 |
Cash Flows from Investing Activities: | ||||||||||||
Investment of cash held in Trust Account | ||||||||||||
105 | 164 | 84 | 254 | 169 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 43,642 |
Cash withdrawn from Trust Account | ||||||||||||
5,635 | 45 | 20,444 | 56 | 9,389 | 0 | 0 | 0 | 0 | - | - | - | - |
Net cash provided by investing activities | ||||||||||||
5,530 | - | - | - | 9,220 | - | - | - | - | - | - | - | - |
Net cash provided by investing activities | ||||||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | -43,642 |
Cash Flows from Financing Activities: | ||||||||||||
Advances from third party | ||||||||||||
- | 0 | 0 | 255 | 170 | 0 | 0 | 0 | 0 | - | - | - | - |
Advance from related party | ||||||||||||
300 | - | - | - | - | - | - | - | - | - | - | - | - |
Proceeds from sale of Units, net of underwriting discounts paid | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 38,800 |
Proceeds from sale of Private Units | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 2,950 |
Proceeds from sale of over-allotment Units, net of underwriting discounts paid | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 2,842 |
Proceeds from sale of Unit Purchase Option | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Payment of offering costs | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 325 |
Proceeds from promissory notes - related parties | ||||||||||||
- | 135 | 85 | 0 | 35 | 100 | 130 | 0 | 0 | - | - | - | - |
Redemption of common stock | ||||||||||||
5,635 | 0 | 20,373 | 0 | 9,305 | 0 | 0 | 0 | 0 | - | - | - | - |
Net cash used in financing activities | ||||||||||||
-5,335 | - | - | - | -9,100 | - | - | - | - | - | - | - | - |
Repayment of promissory notes - related parties | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 120 |
Net cash used in financing activities | ||||||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 44,147 |
Net Change in Cash | ||||||||||||
125 | -17 | 7 | 12 | -22 | -28 | -2 | -56 | -89 | -143 | -102 | -78 | 459 |
Supplemental disclosure of noncash investing and financing activities: | ||||||||||||
Initial classification of common stock subject to possible redemption | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 36,445 |
Change in value of common stock subject to possible redemption | ||||||||||||
31 | 2,023 | 30 | -3 | 63 | -460 | 32 | 37 | 148 | -362 | 0 | -85 | 2,819 |
Reclassification of deferred offering costs to additional paid-in capital | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 138 |